力生制药(002393.SZ)：磷酸腺嘌呤原料药通过上市申请

Core Viewpoint - The company, Lifesun Pharmaceutical (002393.SZ), has received approval from the National Medical Products Administration for the marketing application of Adenosine Phosphate raw material, indicating a significant advancement in its product portfolio [1] Group 1: Product Approval - Lifesun Pharmaceutical has been granted a marketing approval notice for Adenosine Phosphate raw material [1] - Adenosine Phosphate, previously known as Vitamin B4, is essential for the synthesis of DNA and RNA, playing a crucial role in maintaining metabolic functions in living organisms [1] - The clinical applications of Adenosine Phosphate include the prevention and treatment of leukopenia caused by various factors, particularly in patients undergoing chemotherapy and radiation therapy, as well as those affected by benzene poisoning [1]